• Latest Posts

Clinical hold on trial for colorectal cancer drug lifted by FDA

T-cell therapy company AlloVir set to raise $126.6M

Oxford Biomedica sets up new project and signs LSA

Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma

Consortium awarded €4M towards platform for personalized cell therapies

First patient receives new immunotherapy drug for HIV in clinical trial

ADVERTISEMENT

Evotec completes acquisition of Rigenerand

Scancell to produce and clinically validate T cell redirecting bispecific antibodies

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

Boost for dementia gene-based therapies

TILT Biotherapeutics raises $10M to push ahead on cancer immunotherapies

Athersys to restructure – 70% of workforce to go

ADVERTISEMENT